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Vertebrate skeletogenesis involves two pro-
cesses, skeletal patterning and osteoblast
differentiation. Here, we show that Satb2, en-
coding a nuclear matrix protein, is expressed
in branchial arches and in cells of the osteoblast
lineage. Satb2/ mice exhibit both craniofacial
abnormalities that resemble those observed in
humans carrying a translocation in SATB2 and
defects in osteoblast differentiation and func-
tion. Multiple osteoblast-specific genes were
identified as targets positively regulated by
SATB2. In addition, SATB2 was found to repress
the expression of several Hox genes including
Hoxa2, an inhibitor of bone formation and regu-
lator of branchial arch patterning. Molecular
analysis revealed that SATB2 directly interacts
with and enhances the activity of both Runx2
and ATF4, transcription factors that regulate
osteoblast differentiation. This synergy was
geneticallyconfirmedbyboneformationdefects
in Satb2/Runx2 and Satb2/Atf4 double hetero-
zygous mice. Thus, SATB2 acts as a molecular
node in a transcriptional network regulating skel-
etal development and osteoblast differentiation.
INTRODUCTION
Skeletal development is initiated when mesenchymal
cells aggregate at the location of and condense in the
shape of future skeletal elements. These events, referred
to as skeletal patterning, occur at various times through-
out development of the skeleton and are controlled by
major developmental signaling pathways and regulators
of positional identity (Mariani and Martin, 2003). During
craniofacial development, neural crest cells migrate
ventrolaterally from specific segmented regions of thehindbrain, termed rhombomeres, into the branchial arches
to form specific components of the jaw apparatus (Hunt
and Krumlauf, 1991; Bronner-Fraser, 1993; Ko¨ntges and
Lumsden, 1996; Graham and Smith, 2001; Depew et al.,
2002). Key players in these patterning events are, among
others, Hox proteins, which confer anterioposterior posi-
tional identity, and Dlx5 and -6, which regulate dorsoven-
tral patterning (Trainor and Krumlauf, 2001; Depew et al.,
2002; Santagati and Rijli, 2003). Targeted inactivation of
rhombomere-specificHox genes and grafting experiments
of neural crest cells indicate that patterning involves both
segment-restricted Hox gene expression and interactions
of migrating neural crest cells with the respective bran-
chial arch environment (Chiaska et al., 1992; Gendron-
Maguire et al., 1993; Rijli et al., 1993; Veitch et al., 1999).
The second important event during skeletal develop-
ment is the differentiation of cells of various origins into
three specialized cell types: mesenchymal cartilage-form-
ing chondrocytes and bone-forming osteoblasts as well
as myelomonocytic bone-degrading osteoclasts. Few
skeletal elements, including parts of the skull, are gener-
ated by direct differentiation of mesenchymal progenitor
cells into bone-forming osteoblasts in a process termed
intramembraneous ossification; most bones are formed
by endochondral ossification via a cartilagenous template
(Olsen, et al., 2000; de Crombrugghe et al., 2001). Differ-
entiation along the osteoblast lineage has been shown
to depend on three transcriptional regulators. Runx2 and
Osterix are both required for the early and late stages of
osteoblast differentiation, whereby Runx2 is a master reg-
ulator that acts upstream of Osterix (Nakashima et al.,
2002). In addition, Atf4 regulates the terminal differentia-
tion and function of osteoblasts, including the synthesis
of the most abundant bone extracellular matrix protein,
Type I collagen (Yang et al., 2004).
The function of various transcription factors and cis-act-
ing sequences can be regulated by proteins that are part
of the nuclear matrix and bind AT-rich sequences, referred
to as nuclear matrix-attachment regions (MARs; Bode
et al., 2000). MAR sequences and MAR binding proteins
have been implicated in the higher-order organization ofCell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc. 971
chromatin and in the regulation of long-range interactions
between enhancers and promoters (Cockerill and Gar-
rard, 1986; Gasser and Laemmli, 1986; Jenuwein et al.,
1997). Several transcription factors, including Runx2,
have been shown to associate with the nuclear matrix,
and these associations have been implicated in the sub-
nuclear localization and function of these transcription
factors (Zaidi et al., 2005).
SATB2 is a recently clonedmember of the family of spe-
cial AT-rich binding proteins that binds to MARs and acti-
vates transcription in a MAR-dependent manner (Dobreva
et al., 2003; Britanova et al., 2005). In humans, transloca-
tions that involve the chromosomal region 2q32-q33 and
are associated with a cleft palate under conditions of hap-
loinsufficiency have been found to interrupt the SATB2
gene (FitzPatrick et al., 2003). SATB2 is closely related
to the thymocyte-specific SATB1 protein (Kohwi-Shige-
matsu et al., 1997). SATB1 regulates multiple genes and
has been found to act as a repressor of transcription by
recruiting the Sin3a histone deacetylase and subunits of
the ACF nucleosome-mobilizing complex to target genes
(Alvarez et al., 2000; Yasui et al., 2002). In addition, SATB1
has been proposed to act by tethering MAR sequences
onto its ‘‘cage-like’’ proteinaceous scaffold (Cai et al.,
2003).
Here, we analyze the function of SATB2 in skeletogene-
sis.We find that SATB2 represses the expression ofHoxa2
and activates several osteoblast-specific genes by aug-
menting the activity of both Runx2 and ATF4, suggesting
that SATB2 acts as a molecular node in a transcriptional
network regulating skeletogenesis.
RESULTS
Generation of Satb2 Knockout Mice and Analysis
of Satb2 Expression in Development
To gain insight into the physiological role of SATB2, we in-
activated the Satb2 gene in mouse embryonic stem (ES)
cells by homologous recombination and in-frame insertion
of the bacterial b-galactosidase (LacZ) gene immediately
downstream of the first ATG codon in exon 2 (Figure S1A).
Mice carrying a mutant Satb2-LacZ allele were mated to
generate heterozygous and homozygous mutant mice
(Figure S1B; data not shown). Immunoblot analysis of fetal
brain tissue using anti-SATB2 and anti-b-Gal antibodies
indicated that b-galactosidase protein, but not SATB2
protein, is detected in Satb2/ mice (Figure S1C). Thus,
the targeted gene inactivation generated a null mutation
of the Satb2 gene.
We examined the developmental expression pattern
of Satb2 by analyzing the presence of b-galactosidase
activity in heterozygous Satb2+/ mice between E8.5
and E14.5 (Figures 1A and 1B). Whole-mount staining for
b-galactosidase activity revealed expression in the rhom-
bomere region of the hindbrain at E8.5 and in the first
branchial arch at E9. In addition, b-galactosidase activity
was found in the hindgut diverticulum of E9 embryos. At
E10.5, LacZ expression was detected in all four branchial972 Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc.arches, in the apical ectodermal ridge (AER), and in the
zone of polarizing activity of the limb buds. Coronal sec-
tions indicated that LacZ expression is restricted to the
medial portion of the branchial arches (Figure 1A). At
E12.5 and E14.5, we detected abundant LacZ expression
in the cortex of the brain and at sites of bone formation
(Figure 1B). Additional LacZ expression was found in the
spinal cord, kidneys, and the umbilical cord. We also con-
firmed by in situ hybridization that the pattern of LacZ ex-
pression in E15.5 and E16.5 Satb2+/ embryos is virtually
identical to that of endogenous Satb2 transcription in cor-
responding wild-type embryos (Figures 1C and 1D).
Perinatal Lethality, Cleft Palate, and Skeletal
Patterning Defects in Satb2/ Mice
Heterozygous Satb2+/ mice are phenotypically normal
and fertile.Homozygousmutantmice canbeobtainedwith
the expected Mendelian frequency; however, they die im-
mediately after birth. Until E12.5, Satb2/ mice show no
obvious morphological abnormalities, but starting at
E14.5, the mutants can be easily recognized by a shorter
lower jaw (Figure S1D). Alcian Blue/Alizarin Red staining
of skeletal preparations of E17.5 embryos confirmed that
the homozygous mutants have a shortened mandible and
alterations of several intramembraneous bones that are
derived from the first branchial arch (premaxilla, maxilla,
nasal bones, frontal bones, and temporal processes of
the squamousbone; Figures1Eand1F).Moreover, various
skeletal elements that are derived from the second and
third branchial arches, including the lesser horns and the
body of the hyoid bone, are malformed (Figure 1F). In par-
ticular, the lesser horns are fused and showno articulation.
The thyroid cartilage is missing from the laringeal carti-
lages, whereas the aryenoid, cricoid cartilages and the tra-
cheal rings, derivatives of more caudal branchial arches,
are normal (Figure 1F). The skeletal elements of themiddle
ear are also normal in the mutant mice (data not shown).
SATB2 is expressed in the mandibular component of
the first branchial arch, which gives rise to the lower jaw
(Ko¨ntges and Lumsden, 1996; Fitzpatrick et al., 2003).
Histological analysis of the mandible of E18.5 heads in
horizontal sections indicated that the posterior half of
the homozygous mutant mandible appeared normally
shaped and contained Meckel’s cartilage and developing
molar teeth (Figure 2A). In contrast, the anterior part of the
mandible, which contains normally the lower incisors and
the anterior fusion of the Meckel’s cartilage, is missing in
the mutant mandible (Figure 2A). The incisor teeth, which
express high levels of SATB2 in wild-type embryos, are
missing in E17.5 Satb2/ embryos, although developing
tooth germs can be detected at E13.5 (Figures 2B, S1E,
S1F, S1H, and S1I). The molars, which do not express
SATB2, are unaffected in homozygous mutant embryos
(Figures S1G, S1J, and S1K).
Based on the association of a mutation in the human
SATB2 locus with a cleft palate (FitzPatrick et al., 2003),
we examined coronal sections of heads of E17.5 embryos.
Satb2/ embryos show a cleft palate and a significantly
Figure 1. Developmental Expression Pattern of Satb2 and Skeletal Abnormalities in Satb2/ Mice
(A) b-galactosidase staining of E8.5-E10.5 Satb2+/ embryos to detect SATB2-LacZ expression in whole mounts and in a coronal section through an
E10.5 embryo.
(B) Whole-mount b-galactosidase staining of E12.5 and E14.5 Satb2+/ embryos shows LacZ expression in the developing skeleton.
(C and D) In situ hybridization to detectSatb2 transcripts and b-galactosidase staining to detect LacZ expression in sagittal sections of E15.5Satb2+/
embryos (C) and E16.5 tibias (D), showing virtually identical Satb2 and LacZ expression pattern.
(E) Skeletal preparations of E17.5 wild-type (+/+) and mutant (/) embryos, showing craniofacial malformations and shortening of the hindlimbs.
(F) Magnified view of E17.5 heads (left-hand) and dissected hyoid bone and laryngeal cartilages (right-hand). The mandible (md) and maxilla (mx) are
shortened in themutants. The lesser horns (lh) and the body of the hyoid bone (hy) aremalformed, and the thyroid cartilage (tc) is absent in themutant.
fn, frontal bone; na, nasal bone; pa, parietal bone; ip, interparietal bone; sq, squamous bone; cc, cricoid cartilage; tr, tracheal rings.smaller and shorter tongue, relative to wild-type embryos
(Figures 2B, S1H, and S1J). Scanning electron micros-
copy of the oral cavity roof at E14.5 suggested that the
cleft palate defect in the Satb2/ embryos may be the re-sult of a failure in the midline fusion of the palatal shelves
and the drop-down of the tongue (Figure 2C). TUNEL
assays to assess apoptosis and immunohistochemistry
to detect both SATB2-LacZ expression, and BrdUCell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc. 973
Figure 2. Patterning Defects in SATB2-Deficient Mice
(A) Horizontal sections through the lower jaws of wild-type (+/+) and Satb2mutant (/) E18.5 embryos at two different planes, separated by 300 mm
and stained with hematoxylin-eosin alone (a) or together with alcian blue (b). M, Meckel’s cartilage; m, molar tooth; i, incisor tooth.
(B) Coronal sections of E17.5 wild-type and Satb2/ heads showing a cleft palate and the absence of incisors (i). ps, palatal shelves; t, tongue.
(C) Scanning electron micrographs of heads of E14.5 embryos. The palatal shelves of Satb2/ embryos fail to grow toward the fusion line (asterisks),
and the maxillary processes do not converge at the tip of the snout (arrowheads).
(D) BrdU incorporation (green) and b-galactosidase immunohistochemistry (red) in E14.5 embryos show normal proliferation of the SATB2-LacZ-
positive mesenchyme of Satb2/ palatal shelves. White arrows indicate the direction of the maxillary processes.
(E) Whole-mount TUNEL assays on E10.5 embryos showing increased apoptosis in the first branchial arch of Satb2/ embryos (arrowhead).
(F) Quantitative RT-PCR analysis on SATB2-LacZ-expressing cells (dark bars) that have been isolated by flow cytometry from dissected head and
branchial arch regions of Satb2+/ and Satb2/ embryos. Expression levels of candidate target genes in Satb2/ cells, normalized to b-actin,
are presented relative to the expression levels in the Satb2+/ cells. As a control, SATB2-LacZ-nonexpressing cells (open bars) were used.974 Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc.
incorporation indicated that cell proliferation and survival
are normal in the b-Gal-positive mesenchyme of the mu-
tant palatal shelves (Figures 2D and S2A). However, the
Satb2/ palatal shelve mesenchyme generates bulges
not observed in wild-type mice (Figure 2C), suggesting
that the cleft palate may be caused by a patterning defect.
We also examined whether phenotypic changes can be
detected at earlier stages of development and observed
enhanced apoptosis in the first branchial arch of E10.5
SATB2-deficient embryos (Figure 2E).
To gain insight into potential mechanisms underlying
the craniofacial defects, we examined the expression of
candidate genes that have been implicated in the pattern-
ing of branchial arch-derived structures. We performed
quantitative RT-PCR with RNA isolated from cells in the
head and branchial arch regions of E10.5 Satb2+/ and
Satb2/ embryos that have been loaded with the fluoro-
genic b-galactosidase substrate FDG and sorted by flow
cytometry. As a control, we used cells that were negative
for SATB2-LacZ expression. We failed to detect changes
in the expression of Dlx5, Dlx6, Ptx1, Prx1, Prx2, dHand,
and EphA7 (Figure 2F). However, we detected a 5-fold de-
crease in the level of Lhx7 expression and 4- to 6-fold in-
creases in the expression of several Hox genes. In situ hy-
bridizations to detect transcripts of Dlx1, Dlx2, Gsc, Ptx1,
Alx3, andMsx2 did not reveal any obvious differences be-
tween wild-type and Satb2/ embryos; however, the ex-
pression domain of Msx1 is reproducibly extended in the
mandible of E11.5 mutant embryos (Figures 2G and S2C–
S2F; data not shown). Moreover, the expression of Lhx7
was decreased, consistent with the quantitative RT-PCR
analysis (Figure 2G). The expression of Hoxa2 in the bran-
chial arches was found to be relatively normal, although an
upregulation was detected in the fronto-nasal processes
(Figure 2G).
Defects of Osteoblast Differentiation
in Satb2/ Mice
In addition to the craniofacial patterning defects, skeletal
preparations of E15.5 Satb2/ embryos showed delayed
bone formation or mineralization, as assessed by Alizarin
Red-staining (Figure S3A). Staining of developing long
bones with a van Gieson dye that labels collagen fibers
showed that collagen levels are markedly reduced in
E14.5 mutant compared to wild-type embryos, a differ-
ence even more pronounced in E15.5 embryos (Figures
3A and 3B). Electronmicroscopy analysis showed a virtual
absence of osteoid seams in the trabeculae of Satb2/
developing bones, suggesting a defect in extracellular
matrix deposition (Figure S3H). X-gal staining of long
bones of Satb2+/ mice at E17.5 showed that SATB2 is
expressed in the osteoblast lineage but not in chon-
drocytes (Figure 3C). Moreover, immunostaining of wild-
type bones for SATB2 and costaining to detect tartrate-resistant alkaline phosphatase-expressing osteoclasts
indicated that SATB2 is not expressed in osteoclasts
(Figure S3E).
Analysis of molecular markers for osteoblast differenti-
ation indicated that expression of Osterix (Osx) and alka-
line phosphatase (AP) is reduced in long bones of E14.5
Satb2/ embryos (Figure 3A). Von Kossa staining to de-
tect mineral deposits showed that the trabeculae of the
homozygous mutant bone are shorter and thinner than
those of the wild-type bone, whereas the growth plate is
normal (Figures 3D and S3F). Von Kossa staining and
quantitative micro-CT of vertebrae confirmed the marked
defect in the formation of trabeculae and bone volume
(Figures 3E and 3F). We also examined the expression of
bone sialoprotein (Bsp), an early marker for osteoblast
differentiation, and osteocalcin (Ocn), a marker for ter-
minal osteoblast differentiation, by in situ hybridization.
Both markers were downregulated in long bones and cal-
variae of Satb2/ embryos (Figures 3D and S3D; data not
shown). Quantification of the changes in the expression of
these and other genes by real-time RT-PCR with RNA
from calvarial osteoblasts indicated that Ocn and Bsp ex-
pression is reduced in the mutant cells 43-fold and 5-fold,
respectively (Figure 3G). No change of Osterix expression
was detected, whereas the expression of Runx2, Atf4,
Dlx3, and Dlx5 was only modestly decreased (Figure 3G).
Finally, we analyzed in cell culture the ability of Satb2/
osteoblasts to differentiate into cells able to produce and
mineralize an extracellular matrix. The percentage of bone
nodules in Satb2/ osteoblasts was reduced 5-fold rela-
tive to wild-type and heterozygous osteoblasts, whereas
cell proliferation was not altered (Figure S4A; data not
shown). This defect was not rescued by the addition of
bone morphogenetic protein-2 (BMP2), which induces
theexpressionofbothRunx2andSatb2 inwild-typeosteo-
blasts (Figures S4A and S4B).
SATB2 Regulates Multiple Genes in Osteoblasts
and Represses Hoxa2 Expression
To gain insight into the role of SATB2 in osteoblasts, we
performed gene expression profiling by hybridizing RNA
from Satb2+/ and Satb2/ calvarial osteoblasts that had
been sorted for LacZ expression. The microarray analysis
was performed on pools of five to six mice and showed
that the expression of multiple genes, encoding transcrip-
tion factors, extracellular matrix proteins, and growth
factors are consistently deregulated in SATB2-deficient
osteoblasts (Figure 4A). Consistent with the quantitative
RT-PCR analysis of osteoblast cultures, expression ofBsp
was markedly downregulated, whereas the expression
of chondrocyte-specific extracellular matrix proteins (Col-
lagen2a1, Collagen9a1, Matrilin, and Elastin) and chon-
drocyte-specific transcription factors (Sox5 and Sox6)
were found to be upregulated. These changes in gene(G) In situ hybridization on transverse sections of E11.5 wild-type andSatb2/ embryos to detectMsx1 and Lhx7 transcripts (left-hand andmiddle). In
situ hybridization to detect Hoxa2 transcripts in coronal sections of E10.5 embryos (right-hand) shows ectopic Hoxa2 expression in the frontonasal
processes (arrowheads; the section level is indicated at the bottom).Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc. 975
Figure 3. Analysis of Bone Defects in SATB2-Deficient Mice
(A) Van Gieson staining to detect collagen fibers (asterisk) and in situ hybridization to detect transcripts of Osterix (Osx) and alkaline phosphatase (AP)
show the absence of collagen fibers and downregulation of Osx and Ap in E14.5 Satb2/ long bones.
(B) Van Gieson staining and in situ hybridizations to detect transcripts of Collagen1a1 (Col1a1) in E15.5 long bones show the absence of trabeculae in
the mutant (upper panels).
(C) b-galactosidase staining on cryosections of tibias from E17.5 embryos shows SATB2-LacZ expression in osteoblasts.
(D) Von Kossa staining of mineralized extracellular matrix and in situ hybridizations to detect transcripts of bone sialoprotein (Bsp) and osteocalcin
(Ocn) in E17.5 tibias.976 Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc.
expression suggest that the SATB2-deficient osteoblasts
have amore immature phenotype, consistent with their in-
ability to fully differentiate when cultured in vitro (Fig-
ure S4A). Notably, we also found a downregulation of
Lhx7 expression and an upregulation of Hoxa2, which is
also deregulated in the fronto-nasal region of Satb2/
embryos.
In addition to its role in craniofacial patterning, Hoxa2
has been shown to antagonize bone formation (Kanzler
et al., 1998). Consistent with these data, in situ hybridiza-
tions oncoronal sections of E15.5 heads showedamarked
upregulation of Hoxa2 expression in areas of SATB2-defi-
cient calvarial bones that express SATB2-LacZ (Figures
4B and S3C). To confirm this result, we performed quanti-
tative RT-PCR analysis on sorted LacZ-expressing pri-
mary osteoblasts and found that Satb2/ osteoblasts
contained ten times more Hoxa2 transcripts than Satb2+/
cells (Figure 4C). The level of Hoxa2 expression was re-
duced 4-fold in Satb2/ osteoblasts that have been
transduced with a retrovirus expressing SATB2.
The regulation of Hoxa2 gene expression has been an-
alyzed in detail and shown to depend on a set of en-
hancers that control its expression in different tissues
(Tumpel et al., 2002). In particular, the intragenic EI en-
hancer and the downstream EII enhancer were found to
determine Hoxa2 expression in rhombomeres 4 and 2, re-
spectively (Figure 4D; Frasch et al., 1995). In silico analysis
of the Hoxa2 enhancer sequences by the MAR-Wiz algo-
rithm identified a putative MAR element within the EII en-
hancer (Namciu et al., 2004; data not shown). To examine
the binding of SATB2 to these regulatory elements in vivo,
we infected primary osteoblasts with a retrovirus express-
ing FLAG-SATB2 and performed chromatin immunopre-
cipitation (ChIP) using an anti-FLAG antibody (Figure 4E).
The immunoprecipitated chromatin fragments were ana-
lyzed with multiple primer pairs that allow for the amplifi-
cation of different regions of the Hoxa2 enhancers.
SATB2 was found to be bound to this region of the EII en-
hancer but not to the EI enhancer in vivo (Figure 4E). More-
over, binding to the EII enhancer appears to be direct, as
recombinant SATB2 can efficiently bind to an oligonucleo-
tide encompassing sequences of the EII enhancer in
an electrophoretic mobility shift assay (Figure S4C, left-
hand). Finally, the expression of SATB2 was found to
result in a 3- to 5-fold decrease in K4 methylation of his-
tone H3 at the endogenous Hoxa2 gene (Figure S4C,
right-hand).
To assess the regulation of the EII enhancer by SATB2,
we transfected an EII enhancer-luciferase gene construct
into Satb2+/ and Satb2/ osteoblasts. The activity of the
EII enhancer was increased 4-fold in Satb2/ osteoblasts
relative to Satb2+/ cells, whereas the enhancer-less re-porter gene was expressed at similar high levels (Fig-
ure 4F). We also examined the effect of the deletion of
the SATB2 binding region in the context of a transgene,
in which a LacZ gene has been inserted into the Hoxa1
gene downstream of the EII enhancer (Frasch et al.,
1995). Deletion of the MAR resulted in some embryos in
an ectopic expression in the cortex and AER of the limb
buds, sites that normally express SATB2 (Figures 1A
and S4D).
To obtain genetic evidence for the repression of Hoxa2
by SATB2 in osteoblasts, we examined whether the delay
of calvarial bone formation in Satb2/ embryos can be
overcome by inactivation of the Hoxa2 gene. To this end,
we mated Satb2+/ mice with Hoxa2+/ mice and ana-
lyzed compound homozygotes at E18.5. Consistent with
the upregulation of Hoxa2 in the calvariae of Satb2/
embryos, we found that the delay in calvarial bone for-
mation of Satb2/ embryos is largely rescued in
Satb2/Hoxa2/mice (Figure 4G). Taken together, these
data indicate that the repression of Hoxa2 in calvarial
osteoblasts by binding of SATB2 to the EII enhancer is
important for normal osteoblast differentiation.
SATB2 Binds to and Regulates the Bone Sialoprotein
and Osteocalcin Promoters
To assess the role of SATB2 in the regulation of Bsp and
Ocn, we performed quantitative RT-PCR with RNA from
primary osteoblasts that had been sorted for LacZ expres-
sion and cultured in vitro. In Satb2/ cells, we detected
a 12-fold and 6-fold downregulation of Bsp and Ocn, re-
spectively, whereas the expression of these genes was
increased to normal levels in Satb2/ cells that had
been transducedwith a SATB2-expressing retrovirus (Fig-
ure 5A). Previous studies of the bone sialoprotein (Bsp)
promoter have identified three regulatory sequence ele-
ments in a region between290 and181 that determine
osteoblast-specific promoter activity (Figure 5B; Benson
et al., 2000). ChIP analysis of wild-type osteoblasts
that had been infected with a retrovirus expressing
FLAG-tagged SATB2 showed binding of SATB2 to Bsp
sequences that include the three osteoblast-specific
sequence elements (Figure 5B, lower panel). No binding
of SATB2 was detected with primers that amplify an up-
stream Bsp promoter region. In an EMSA we found that
recombinant SATB2 efficiently bound to a Bsp oligonucle-
otide encompassing the wild-type site C but not to an
oligonucleotide carrying mutations that have been previ-
ously shown to impair Bsp promoter activity (Figure 5D,
left-hand; Benson et al., 2000).
The Ocn promoter has been extensively studied and
shown to be regulated by Runx2 and ATF4, which bind
the nonadjacent sequence elements OSE2 and OSE1,(E) Von Kossa staining in vertebrae sections of wild-type and Satb2/ embryos at E17.5 and E18.5.
(F) Micro-CT analysis of P0 wild-type and Satb2/ vertebrae. Note the decrease in bone volume/ total bone volume (BV/TV), trabeculae number per
mm (TbN/mm), and trabecular thickness (TbTh) in Satb2/ mice.
(G) Quantitative RT-PCR analysis to determine the relative expression levels of osteoblast-specific genes in Satb2+/ and Satb2/ osteoblasts,
sorted for LacZ expression without in vitro culture. Error bars represent the standard deviation of four experiments.Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc. 977
Figure 4. Identification of SATB2 Target Genes and Regulation of Hoxa2 Expression by SATB2
(A) Affymetrix GeneChip array analysis of Satb2+/ and Satb2/ osteoblasts sorted for LacZ expression. The fold changes in transcript levels in
Satb2/ cells, relative to Satb2+/ cells, are indicated.
(B) In situ hybridization of E15.5 heads (one hemisphere is shown) reveals ectopic expression of Hoxa2 in Satb2/ calvariae (boxed area).
(C) Quantitative RT-PCR analysis detects an upregulation of Hoxa2 expression in Satb2/ osteoblasts but not in mutant cells that have been trans-
duced with a SATB2-expressing retrovirus 48 hr prior to the analysis. The levels of gene expression in Satb2/ osteoblasts (black bars) and Satb2-
transduced Satb2/ osteoblasts (gray bars) are presented relative to Satb2+/ osteoblasts (white bars). The data are averages plus standard devi-
ation of four independent experiments.978 Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc.
Figure 5. SATB2 Regulates the Expression of Bsp and Ocn
(A) Quantitative RT-PCR analysis of sorted SATB2-deficient osteoblasts that had been transduced with a Satb2-expressing retrovirus (gray bars)
shows a reversal of Bsp and Ocn downregulation relative to Satb2+/ cells (white bars). The data are averages plus standard deviation of four inde-
pendent experiments.
(B) Detection of SATB2 binding to the Bsp promoter by ChIP analysis. Schematic representation of the regulatory elements in the Bsp promoter, in-
cluding three osteoblast-specific elements, A–C (Benson et al., 2000; upper panel). ChIP on FLAG-SATB2 transduced osteoblasts detects specific
binding of SATB2 to the Bsp promoter region.
(C) Schematic representation of the Ocn promoter showing the positions of the binding sites for ATF4 (OSE1) and Runx2 (OSE2) (upper panel). The
ChIP analysis detected binding of FLAG-SATB2 to a promoter fragment containing OSE1 and OSE2.
(D) Electrophoretic mobility shift assay (EMSA) showing binding of purified recombinant SATB2 to wild-type (wt), but not mutated (mut), Bsp site C
oligonucleotides (left panel). No SATB2 binding was detected to wild-type OSE1 and OSE2 oligonucleotides (right panel). The MAR consensus
oligonucleotide was used as a positive control.
(E) Quantitative RT-PCR analysis to determine the levels of endogenous Bsp and Ocn expression in C2C12 cells that had been transduced with
a SATB2- or GFP-expressing retrovirus. Cells were either untreated or treated with the proteasome inhibitor MG115. The data are averages plus stan-
dard deviation of four independent experiments.
(F) ChIP assay to detect changes in H3 acetylation and pol II occupancy at theOcn promoter inSatb2/ (black bars) andSatb2- transducedSatb2/
osteoblasts (gray bars). Error bars represent the standard deviation of three experiments.respectively (Figure 5C; Bidwell et al., 1993; Ducy and Kar-
senty, 1995; Yang et al., 2004). To determine whether
SATB2 is bound to theOcnpromoter in vivo,weperformedChIP experiments with primary wild-type osteoblasts
that had been infected with a FLAG-SATB2-expressing
retrovirus or a GFP-expressing control virus.(D) Schematic representation of theHoxa2 gene and its regulatory sequences. The primer pairs used for the chromatin immunoprecipitation (ChIP) are
shown as arrowheads.
(E) ChIP assay to detect SATB2 binding in primary osteoblasts that had been infected with a retrovirus expressing FLAG-Satb2. PCR products were
amplified from 3-fold serial dilutions of anti-FLAG immunoprecipitated chromatin fragments.
(F) Analysis of EII enhancer activity in sorted Satb2+/ and Satb2/ osteoblasts that have been transfected with a fos-luciferase construct containing
or lacking the Hoxa2 EII enhancer. Error bars represent the standard deviation of three experiments.
(G) Top view of Alizarin Red/ Alcian Blue-stained skulls of E18.5 wild-type, Satb2/, Hoxa2/, and Satb2/Hoxa2/ embryos. The frontal (fn),
parietal (pa), and interparietal (ip) bones are indicated. Bone formation is decreased in Satb2/, and this defect is largely rescued (asterisks mark
edges of the frontal and interparietal bones) in Satb2/Hoxa2/ embryos.Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc. 979
Immunoprecipitation with anti-FLAG antibody and ampli-
fication with primers flanking the proximal OSE2 and
OSE1 sequences indicated that SATB2 is bound to the en-
dogenous Ocn promoter (Figure 5C, lower panel). How-
ever, we failed to identify putative MAR elements using
the MAR-Wiz algorithm and were unable to detect binding
of SATB2 to either OSE2 or OSE1 in an EMSA (Figure 5D,
right-hand).
To obtain further evidence for a role of SATB2 in the reg-
ulation of Bsp and Ocn, we examined whether forced ex-
pression of SATB2 induces the expression of the endo-
genous genes. To this end, we infected C2C12 cells with
a GFP- or SATB2-expressing retrovirus and analyzed
Bsp and Ocn expression by quantitative RT-PCR. In
SATB2-expressing cells, Bsp expression was increased
12-fold, whereas Ocn expression was not significantly
altered (Figure 5E). Based on the noted similarity of the
bone phenotype in Satb2/ and Atf4/ mice, we exam-
inedwhether SATB2 could induceOcn expression in com-
bination with ATF4. We treated cells with the proteasome
inhibitor MG115, which has been previously shown to sta-
bilize ATF4 andRunx2 and increaseOcn expression (Yang
and Karsenty, 2004). As anticipated, MG115 treatment
augmented Ocn expression 25-fold, and this activation
was further enhanced by a factor of seven in SATB2-
expressing cells (Figure 5E). Finally, we found that the
forced expression of SATB2 in Satb2/ osteoblasts in-
creased the acetylation of histone H3 and the RNA poly-
merase II occupancy of the Ocn promoter, relative to
SATB2-deficient cells (Figure 5F).
Cooperation of SATB2 with Both ATF4 and Runx2
The augmentation ofOcn expression by SATB2 raised the
question of whether SATB2 interacts functionally or phys-
ically with Runx2 and/or ATF4, the two key regulators of
Ocn. To this end, we transfected transiently COS7 cells
with an Ocn-luciferase reporter, alone or together, with
various combinations of expression plasmids for SATB2,
Runx2, and ATF4 (Figures 6A and S5). Individually,
Runx2, but not SATB2 or ATF4, augmented the activity
of the 647bp Ocn promoter fragment. However, SATB2
augmented the Runx2-mediated activation by a factor of
three, and this stimulation was further enhanced by the
co-expression of ATF4 (Figure 6A). To examine whether
SATB2 directly stimulates the activation by ATF4 or
Runx2, we used reporter plasmids that contain multimer-
ized ATF4 binding sites (6xOSE1-luciferase; Figure 6B) or
multimerized Runx2 binding sites (6xOSE2-luciferase;
Figure 6C). SATB2 alone did not activate these reporters,
but it augmented ATF4- and Runx2-mediated activation
by factors of two and four, respectively (Figures 6B and
6C, black bars). As a control, SATB2 had no effect on re-
porters in which the ATF4- or Runx2 binding sites had
been mutated (Figures 6B and 6C, white bars).
To delineate the domains of Runx2 and ATF4 that medi-
ate the functional collaboration with SATB2, we trans-
fected various deletion constructs of Runx2 and ATF4
together with a SATB2 expression plasmid. Deletion of980 Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc.the 108 amino-terminal residues of Runx2 abrogated the
collaboration with SATB2, whereas the other deletions
impaired activation of the 6xOSE2 reporter but did not
affect stimulation by SATB2 (Figure 6D). Likewise, deletion
of the 199 amino-terminal residues of ATF4 impaired the
collaboration with SATB2 (Figure 6E).
Finally, we determined the effects of SATB2 on DNA
binding by ATF4 and Runx2. We performed an EMSA
with nuclear extracts from Ros cells, which contain en-
dogenous Runx2 and ATF4 and have been infected with
a SATB2- or GFP-expressing retrovirus (Figure 6F). Bind-
ing of ATF4 to OSE1 and Runx2 to OSE2 was detected,
and the identities of the protein:DNA complexes were
confirmed by the addition of anti-ATF4 or anti-Runx2
antibodies. No effect was observed by the addition of an
anti-fos antibody. In extracts containing SATB2, an en-
hancement of DNA binding by both ATF4 and Runx2
was detected but without the appearance of slower-
migrating protein:DNA complexes (Figure 6F).
Physical and Genetic Interaction of SATB2 with ATF4
and Runx2
To gain further insight into the collaboration of SATB2 with
ATF4 and Runx2, we performed coimmunoprecipitations
with extracts from 293 cells that had been transiently
transfected with FLAG epitope-tagged SATB2 and vari-
ous deletion constructs of Runx2 and ATF4 (Figures 7A
and 7B). Immunoprecipitations with an anti-FLAG
antibody and subsequent immunoblot analysis with an
anti-Runx2 antibody directed against amino-terminal
sequences indicated that Runx2 and various C-terminal
deletions are efficiently coimmunoprecipitated with
FLAG-SATB2 (Figure 7A). To examine the effects of the
deletion of the amino-terminal sequences of Runx2, we
used His-tagged Runx2 constructs and found that the
same region that mediates the functional collaboration
with SATB2 is also required for coimmunoprecipitation
(Figure 7A). Likewise, we also detected efficient coimmu-
noprecipitation of Myc-tagged and endogenous ATF4
with anti-FLAG antibody (Figure 7B). In this experiment,
we could detect coimmunoprecipitation of the amino-ter-
minal 200 residues of ATF4 (Figure 7B, lower panel) and
failed to coimmunoprecipitate the C-terminal residues
(Figure 7B, upper panel). To determine whether the inter-
actions of SATB2 with ATF4 and Runx2 are based on di-
rect physical association, we performed His- and GST-
pulldown experiments with purified recombinant proteins
(Figure 7C). These experiments indicated that immobilized
SATB2 could efficiently interact with ATF4, and reciprocal
associations of SATB2 were detected with both ATF4 and
Runx2. Taken together, these data show that SATB2 can
physically interact with both ATF4 and Runx2, resulting in
enhanced DNA binding and transactivation by these
transcription factors.
To confirm the functional importance of the interactions
detailed above in vivo, we examined whether the Satb2,
Runx2, and Atf4 genes interact genetically. We crossed
Satb2+/ and Atf4+/ mice and analyzed bone
Figure 6. Functional Collaboration of SATB2 with ATF4 and Runx2
(A) COS7 cells were transiently transfected with a luciferase reporter construct containing a 647bp Ocn promoter fragment alone or together with
SATB2, Runx2, and ATF4 expression plasmids in various combinations. The luciferase levels were normalized for the b-galactosidase activity of
a cotransfected RSV-lacZ reporter and presented as fold activation relative to the luciferase levels of the Ocn reporter construct alone.
(B and C) COS7 cells were cotransfected with a luciferase reporter containing multimerized wild-type or mutated OSE1 (B) or OSE2 (C) sites alone or
together with SATB2, ATF4, and Runx2 expression plasmids.
(D) Mapping of the SATB2 interaction domain in Runx2 by transfection of COS7 cells with SATB2 and different deletion mutants of Runx2.
(E) SATB2 functionally interacts with the N-terminal part of ATF4. COS7 cells were cotransfected with an OSE1-luciferase reporter together with
SATB2 and ATF4 constructs. Error bars in (A), (B), (C), (D), and (E) represent the standard deviation of duplicate transfections.
(F) SATB2 enhances the binding of ATF4 and Runx2 to their respective binding sites. EMSA of nuclear extracts (2 mg) from ROS17 osteosarcoma cells
infected with either GFP- or SATB2-expressing retroviruses to detect binding of ATF4 and Runx2 to OSE1 (lanes 1–5) and OSE2 (lanes 6–10) oligo-
nucleotides, respectively. Sp1 binding served as a control for the quality and quantity of the extracts (not shown). The identity of the protein:DNA
complexes was confirmed by their reactivity with anti-ATF4 or anti-Runx2 antibodies. Anti-Fos antibody was used as a negative control.development by van Gieson staining of E15.5 long bones.
Satb2+/ and Atf4+/ bones showed normal formation of
trabeculae and collagen fibrils, whereas double heterozy-
gous bones displayed a marked reduction of bone forma-
tion (Figure 7D). Van Gieson staining of E17.5 long bones
ofSatb2/Runx2 double heterozygous and single heterozy-
gous embryos revealed a significant bone defect in the
double heterozygotes, which was further corroborated by
micro-CT analysis of vertebrae at birth (Figures 7E and
7F). The bone volume/total volume was reduced from
15.51% in wild-type mice to 3.53% in Satb2+/Runx2+/
mice and 8.53% in Satb2+/Atf4+/ mice. Moreover, the
trabecular numbers/mm were reduced form 4.54 in wild-
type mice to 0.79 in Satb2+/Runx2+/ mice and 2.48 in
Satb2+/Atf4+/ mice. Finally, we examined whether the
genetic interaction of SATB2 with Runx2 could have a
role in early stages of osteoblast differentiation. Indeed,
in situ hybridization of Satb2 and Runx2 single and double
heterozygous E15.5 bones to detect transcripts of theearly molecular markers of bone formation, Osx and AP,
showed a significant decrease in compound heterozy-
gous embryos. Thus, Satb2 interacts genetically with
both Atf4 and Runx2 (Figure 7E).
DISCUSSION
Regulation of Craniofacial Patterning by SATB2
In the developing mouse, starting at E8.5, Satb2 is ex-
pressed in the rhombomere region, at E9.0 in the first
branchial arch, and subsequently in the medial parts of
all four branchial arches that give rise to various facial
structures of the adult (Hunt and Krumlauf, 1991; Bron-
ner-Fraser, 1993; Ko¨ntges and Lumsden, 1996). Consis-
tent with this expression pattern, Satb2/ embryos
show multiple craniofacial defects that include a signifi-
cant truncation of the mandible, a shortening of the nasal
and maxillary bones, malformations of the hyoid bone,
and a cleft palate. By analyzing the expression of severalCell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc. 981
Figure 7. Physical and Genetic Interactions of SATB2 with ATF4 and Runx2
(A) Coimmunoprecipitation of Runx2 with FLAG-SATB2 in transiently transfected 293 cells. Immunoprecipitation (IP) was performed with an
anti-FLAG antibody, and Runx2 proteins were detected by immunoblot (IB) analysis with anti-Runx2 (generated against the N terminus) or anti-His
antibodies.
(B) Coimmunoprecipitation of ATF4 with FLAG-SATB2 in transfected 293 cells. ATF4 proteins were detected by immunoblot analysis with anti-ATF4
(generated against the C terminus) (upper panel) or anti-myc antibodies (lower panel). To increase the endogenous protein levels of ATF4, cells were
treated with MG115.
(C) SATB2 binds directly to Runx2 and ATF4 in a His-tag pulldown with nickel beads (upper panel) or GST pulldown with glutathione beads (middle
and lower panels).
(D) Van Gieson staining of collagen fibrils in E15.5 bones of wild-type (WT), Satb2, Atf4 single, and double heterozygous mice. Trabeculae along the
bone collar were detected in wild-type, Satb2+/, and Atf4+/ bones (arrowheads) but not in the compound mutant.982 Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc.
genes implicated in craniofacial development, we identi-
fied Lhx7 and several Hox genes as potential target genes
for SATB2. Targeted inactivation of Lhx7, also termed
Lhx8, results in a defect in the fusion of the palatal shelves
but does not impair the development of other oral struc-
tures that are affected in Satb2/ embryos (Zhao et al.,
1999). Moreover, mice homozygous for a null mutation
of theMsx1 gene, which has an altered pattern of expres-
sion in Satb2/ embryos, display a cleft palate (Satokata
and Maas, 1994). The function of SATB2 in regulating pal-
atogenesis is probably conserved during evolution as hu-
mans carrying deletions and balanced translocations in-
volving chromosome 2q32-q33, which includes the
SATB2 locus, show a failed fusion of the secondary pal-
ate, which is also observed in Satb2/ mice (FitzPatrick
et al., 2003).
Targeted inactivation of Hoxa2, which is expressed in
the epithelium of rhombomere r2 and in the migrating neu-
ral crest of r4, results in the transformation of second arch-
specific skeletal elements into first arch-specific elements
(Gendron-Maguire et al., 1993; Rijli et al., 1993). The struc-
tures altered in Hoxa2/ embryos appear to be normal in
Satb2/mice and, therefore, we consider it likely that ad-
ditional SATB2-regulated genes contribute to the cranio-
facial defects in Satb2/ embryos.
Regulation of Hoxa2 by SATB2 in the Osteoblast
Lineage
Beside defects in branchial arch patterning, Hoxa2/
mice show an upregulation of the cartilage- and bone-
specifying genes Sox9 and Runx2 (Kanzler et al., 1998).
Consistent with a function of Hoxa2 in antagonizing
bone formation, transgenic overexpression of Hoxa2 in
dermal bone precursors of the craniofacial area inhibits
the formation of dermal bones, and the loss of Hox gene
expression in cultured trunk neural crest cells correlates
with the adoption of a skeletogenic fate (Kanzler et al.,
1998; Creuzet et al., 2002). Interestingly, we detect an ec-
topic upregulation of Hoxa2 in the forming calvarial bones
of Satb2/ embryos at E15.5, and we could confirm the
upregulation of Hoxa2 and Hoxb2 by quantitative RT-
PCR assays with RNA from sorted osteoblasts (Figures
4B and 4C). Moreover, the rescue of the calvarial bone
formation defect in Satb2/Hoxa2/ mice suggests
that the repression of Hoxa2 by SATB2 is important for
normal osteoblast differentiation.
The regulation of Hoxa2 has been studied extensively
and shown to involve distinct cis-acting elements that me-
diate expression in the hindbrain and in neural crest cells
(Tumpel et al., 2002). In particular, an enhancer in the 30 re-
gion of the Hoxa2 gene, which has been implicated in au-
toregulation, has been found to direct LacZ expression in
r2 and rostral somites (Frasch et al., 1995; Lampe et al.,2004). In vivo and in vitro, we detected binding of SATB2
to a sequence of the EII enhancer that has the hallmarks
of a MAR. A similar sequence is also found at the 30 end
of the Hoxb2 gene that is bound by SATB2 as determined
in ChIP experiments (unpublished observation). More-
over, we show that the activity of the Hoxa2 EII enhancer
can be repressed by SATB2 in transfected osteoblasts,
and we find that deletion of the MAR region in the context
of a Hoxa2 transgene can result in the ectopic expression
in regions that are positive for SATB2 expression in wild-
type embryos. Taken together, our data suggest that
SATB2 plays a role in downregulating Hoxa2 expression
in osteoblasts.
Regulation of Osteoblast Differentiation
and Function by SATB2
During skeletogenesis, the function of SATB2 is not re-
stricted to the patterning of the craniofacial region. In-
deed, later stages of Satb2/ embryos show a delay in
bone formation as characterized by a virtual absence of
collagen deposition in E15.5 embryos. We also observed
a marked decrease in the terminal differentiation of
Satb2/ osteoblasts, as determined by an absence of
Bsp and Osn expression. The similarity between the oste-
oblast phenotype of Satb2/ and Atf4/ mice sug-
gested that the two proteins may interact physically and/
or functionally with each other. Indeed, our molecular
and genetic analysis indicated that Satb2 interacts not
only with ATF4 but also with Runx2. SATB2 can physically
interact with both ATF4 and Runx2 and enhance the trans-
activation function of both proteins. Importantly, the same
regions of ATF4 and Runx2 that mediate the functional
synergy are also involved in the physical association
with SATB2. The interaction of SATB2 with ATF4 and
Runx2 augment their binding to the cognate DNA-recog-
nition elements, although SATB2 does not bind itself to
the OSE1 and OSE2 sequences. However, this mode of
action of SATB2 does not exclude the possibility that it
can function as a DNA bound protein. SATB2 has been
shown to recognize specific sequences, termed MAR se-
quences (Dobreva et al., 2003), and indeed, SATB2 was
found to regulate the Bsp promoter by binding to a site
that resembles a bona fide MAR element. Moreover,
SATB2 represses Hoxa2 expression in osteoblasts
through direct recognition of aMAR-like sequence. There-
fore, SATB2 may act both as a transcriptional regulator
that binds to specific DNA sequences and as a ‘‘scaffold-
ing’’ protein that recruits other DNA bound proteins to
specific subnuclear sites. This potentially dual function
of SATB2may also explain why Atf4/mice have defects
that resemble some but not all defects found in Satb2/
mice. Finally and more importantly, Satb2 interact geneti-
cally with bothAtf4 andRunx2 as the double heterozygous(E) Top panel: Van Gieson staining of long bones of E17.5 Satb2, Runx2 single and double heterozygous mice shows a virtual absence of trabeculae
(arrowheads) in the double heterozygote. Middle and bottom panels: In situ hybridizations to detect transcripts of alkaline phosphatase (AP) and
Osterix (Osx) in E15.5 wild-type, Satb2+/, Runx2+/, and Satb2+/ Runx2+/ tibias.
(F) Micro-CT analysis on vertebrae from P0 wild-type, Satb2+/, Atf4+/, Runx2+/, Satb2+/ Atf4+/, and Satb2+/ Runx2+/ mice.Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc. 983
Figure 8. Model for a Transcriptional
Network in Skeletal Development, in
Which SATB2 Regulates This Process
by Repressing Hoxa2 and Augmenting
the Functions of the Osteoblast Determi-
nants Runx2 and ATF4
SATB2 can activate or repress gene transcrip-
tion by direct binding to DNA, and it can act as
a scaffold that enhances the activity of other
DNA binding proteins.mutantmice display a severe defect in bone development,
which is not observed in single heterozygousmutantmice.
Our molecular and genetic analysis also indicated that the
interaction of SATB2 with Runx2 may be functionally even
more important than the interaction with ATF4 because
Satb2+/Runx+/ embryos have a more severe osteopo-
rotic phenotype than Satb2+/Atf4+/ embryos. In addi-
tion, many genes that are deregulated in Satb2/ osteo-
blasts are known targets of Runx2.
Previous analysis of the osteocalcin promoter, a well-
studied model for osteoblast-specific gene expression,
has indicated that Runx2 and ATF4 synergize via nonadja-
cent binding sites (Xiao et al., 2005). As ATF4 and Runx2
do not interact directly, it has been proposed that an addi-
tional protein mediates the functional synergy between
these transcription factors. Our findings that SATB2 inter-
acts with both Runx2 and ATF4 and augments their syner-
gistic activation suggest that SATB2 may act to couple
these osteoblast-specific transcription factors. Although
this interaction enhances the binding of ATF4 and Runx2
to the osteocalcin promoter in vitro, this effect is modest
and cannot explain the marked functional synergy. There-
fore, SATB2 may participate in recruitment of proteins to
specific subnuclear sites. Runx2 has been originally iden-
tified as NMP2, an osteoblast-specific MAR binding pro-
tein that associates with the nuclear matrix via a C-termi-
nal targeting sequence and acts as a scaffold that targets
regulatory factors and gene sequences to specific subnu-
clear sites (Bidwell et al., 1993; Choi et al., 2001; Zaidi
et al., 2005). However, SATB2 interacts with the amino-
terminal domain of Runx2, which is also required for the
functional synergy of Runx2 with ATF4. Moreover,
SATB2 does not appear to mediate subnuclear targeting
of Runx2, as the punctate nuclear distribution of Runx2
is not altered in Satb2/ osteoblasts (data not shown).984 Cell 125, 971–986, June 2, 2006 ª2006 Elsevier Inc.Therefore, we favor the view that SATB2may act to recruit
ATF4 to Runx2 multiprotein complexes in osteoblasts.
In conclusion, SATB2 is an unusual molecular determi-
nant of skeletal development. It can act not only as an ac-
tivating or repressing DNAbound protein but also as a pro-
tein scaffold that enhances the activity of other DNA
binding proteins (Figure 8). By its ability to regulate the ex-
pression or activity of multiple key determinants of skeletal
development, SATB2 appears to represent a molecular
node of a transcriptional network underlying this process.
EXPERIMENTAL PROCEDURES
Satb2 Gene Targeting
A b-galactosidase/pGKneo-pA cassette was inserted in frame with
the ATG codon of the SATB2 gene. Homologous recombination was
identified by Southern blot analysis with 50 internal and 30 external
probes. Embryos were genotyped by PCR on DNA obtained from
the yolk sacs or tail biopsies. Primer sequences for amplifying the
homology arms of the targeting construct and for genotyping are
provided upon request.
Morphological Analysis and In Situ Hybridization
For skeletal preparation, embryos were fixed in 95% ethanol. Alcian
Blue/Alizarin Red staining was performed according to standard pro-
tocols. For histological analysis, embryos were fixed with 4% parafor-
maldehyde, embedded in paraffin, sectioned in 7mm thick slices, and
stained with hematoxylin/eosin, von Kossa, and van Gieson reagents
according to standard protocols. The micro-CT analysis was per-
formed using the mCT40 Scanner according the standard criteria (Val-
entin et al. 2003). LacZ staining and in situ hybridizations were per-
formed on 20 mm thick cryosections. For detailed information, see
Supplemental Experimental Procedures.
Cell Culture, Transient Transfections, and Reporter Assays
Primary osteoblasts were isolated from E18.5 embryos essentially as
described (Ducy and Karsenty, 1995). C2C12 and COS7 cells were
grown in a-MEM supplemented with 10% fetal bovine serum.
Transient transfections were performed using Lipofectamine (invitro-
gen) according to the manufacturer’s instructions.
Protein Expression, Pull-Down Assays, EMSA,
Immunoprecipitation, and Immunoblot Analysis
Recombinant proteins were expressed and purified, and pull-down as-
says were performed as previously described (Dobreva et al., 2003;
Yang et al., 2004). EMSA, coimmunoprecipitation, and chromatin im-
munoprecipitations were performed as described (Dobreva et al.,
2003). For oligonucleotides and primers, see Supplemental Experi-
mental Procedures. For immunoblot analysis, antibodies were used
in the following dilutions: anti-His (Santa Cruz) 1:1000; anti-ATF4
(Santa Cruz) 1:500; anti-Runx2 1:2000; and anti-b galactosidase
1:5000.
RNA Isolation, RT-PCR, and Real-Time PCR
RNA was isolated using the Trizol reagent. Real-time PCR was per-
formed with SYBR GREEN PCR master mix (Applied Biosystems)
using the ABI PRISM 7000 sequence detection system. The cycle
numbers were normalized to b-actin. Primer pairs are described in
Supplemental Experimental Procedures.
FDG Loading and FACS Sorting
For the sorting of SATB2-LacZ positive cells, osteoblasts were loaded
with fluorescein digalactoside (Molecular Probes) using hypotonic
shock according to themanufacturer’s instructions. After FDG loading,
the cells were kept on ice for 30min before FACS sorting and sorted on
a Vantage cell sorter using the CellQuest software.
Supplemental Data
Supplemental Data include five figures and Experimental Procedures
and can be found with this article online at http://www.cell.com/cgi/
content/full/125/5/971/DC1/.
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